bosentan intas bosentan (as monohydrate)125 mg film-coated tablets bottle pack
accord healthcare pty ltd - bosentan monohydrate, quantity: 129.08 mg (equivalent: bosentan, qty 125 mg) - tablet, film coated - excipient ingredients: magnesium stearate; purified water; sodium starch glycollate type a; maize starch; pregelatinised maize starch; povidone; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red - bosentan intas is indicated for the treatment of ? idiopathic pulmonary arterial hypertension ? familial pulmonary arterial hypertension ? pulmonary arterial hypertension associated with scleroderma or ? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms.
bosentan intas bosentan (as monohydrate) 62.5 mg film-coated tablets bottle pack
accord healthcare pty ltd - bosentan monohydrate, quantity: 64.54 mg (equivalent: bosentan, qty 62.5 mg) - tablet, film coated - excipient ingredients: maize starch; purified water; povidone; magnesium stearate; pregelatinised maize starch; sodium starch glycollate type a; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red - bosentan intas is indicated for the treatment of ? idiopathic pulmonary arterial hypertension ? familial pulmonary arterial hypertension ? pulmonary arterial hypertension associated with scleroderma or ? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms.
bosentan intas bosentan (as monohydrate) 125 mg film-coated tablets blister pack
accord healthcare pty ltd - bosentan monohydrate, quantity: 129.08 mg (equivalent: bosentan, qty 125 mg) - tablet, film coated - excipient ingredients: pregelatinised maize starch; magnesium stearate; sodium starch glycollate type a; maize starch; povidone; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red - bosentan intas is indicated for the treatment of ? idiopathic pulmonary arterial hypertension ? familial pulmonary arterial hypertension ? pulmonary arterial hypertension associated with scleroderma or ? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms.
intaszoryl-1mg tablets
jetpharma sdn. bhd. - glimepiride -
intaszoryl-2mg tablets
jetpharma sdn. bhd. - glimepiride -
intaszoryl-3mg tablets
jetpharma sdn. bhd. - glimepiride -
intaszoryl-4mg tablets
jetpharma sdn. bhd. - glimepiride -
quinintas - 100mg infusion
intas pharmaceuticals ltd corporate house near sola bridge, s.g highway - enrofloxacin usp - infusion - enrofloxacin usp 100mg - fluoroquinolones
intas fsh amp inj
intas - gonadotrophin f.s.h./urofollitrophin - inj - 150iu.(highly urofolitropine)+ manntiol 10mg - amp
intas fsh amp inj
intas - gonadotrophin f.s.h./urofollitrophin - inj - 75iu.(highly urofolitropine)+ manntiol 10mg - amp